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Abstract
Background: Geographical and temporal diffusion patterns of a human pandemic due to Swine
Origin Influenza Virus (S-OIV) remain uncertain. The extent to which national and international
pandemic preparedness plans and control strategies can slow or stop the process is not known.
However, despite preparedness efforts, it appears that, particularly in the USA, Mexico, Canada
and the UK, local chains of virus transmission can sustain autonomous dynamics which may lead to
the next pandemic. Forecasts of influenza experts usually rely on information related to new
circulating strains.
Methods: We attempted to quantify the possible spread of the pandemic across a network of 52
major cities and to predict the effect of vaccination against the pandemic strain, if available.
Predictions are based on simulations from a stoch a s t i c  S E I R  m o d e l .  P a r a m e t e r s  u s e d  i n  t h e
simulations are set to values consistent with recent estimations from the outbreak in Mexico.
Results: We show that a two-wave pandemic dynamic may be observed in Southern hemisphere
because of seasonal constraints for a maximum value of the basic reproductive number (R0, max)
within a city equal to 1.5 and a mean generation interval (GI) of 2 days. In this case and in the
absence of vaccination, attack rates may reach 46% when considering a completely susceptible
population. More severe scenarios characterized by higher values of R0, max (2.2) and GI (3.1) yield
an attack rate of 77%. By extrapolation, we find that mass vaccination in all countries (i.e. up to 50%
of the population) implemented 6 months after the start of the pandemic may reduce the
cumulative number of cases by 91% in the case of the low transmissible strain (R0, max = 1.5). This
relative reduction is only 44% for R0, max = 2.2 since most of the cases occur in the first 6 months
and so before the vaccination campaign.
Conclusion: Although uncertainties remain about the epidemiological and clinical characteristics
of the new influenza strain, this study provides the first analysis of the potential spread of the
pandemic and first assessment of the impact of different immunization strategies.
Background
Within 15 days of the WHO's raising the pandemic threat
level to 6, more countries are affected by the new Swine
Origin Influenza Virus (S-OIV) further raising concerns
that S-OIV may be the next pandemic influenza strain.
Active autonomous chains of transmission have been
reported in several countries, such as Mexico, the USA,
Canada, Spain and the UK. Most information about the
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virus and disease so far suggests a regular influenza proc-
ess with many characteristics similar to those documented
in past influenza pandemics [1]. Estimates of reproductive
rates, higher than for seasonal influenza, are consistent
with past pandemics [2,3]. Even if the possibility of a
1918-like scenario seems unlikely with the current circu-
lating virus, the severity of the disease remains uncertain.
Importantly, the underlying pathologies and causes of
death in patients with S-OIV remain poorly documented,
making the future burden of any pandemic uncertain. A
major public health question as the disease continues to
spread is identifying the likely course of the pandemic as
well as possible control measures and their likely impact.
Mathematical modelling has proven effective in retrospec-
tively predicting the global circulation of the 1968–69
influenza pandemic, starting from Hong Kong and using
coupled local epidemic processes [4,5]. Here, we aim at
predicting the pattern of global spread of the potential S-
OIV pandemic flu and at estimating the effect of vaccina-
tion campaigns under different scenarios.
Methods
The model implements a metapopulation approach [4-6]
where coupling between cities is through transportation
(data on daily passengers flows from [7]). It simulates the
spread of a pandemic through a worldwide network of 52
major cities. In each city, the progression of the disease is
tracked by defining four disease states (Susceptible,
Exposed, Infectious, Removed; S, E, I, R) and the transi-
tion rates between them. The exposed individuals (E) are
not infectious and are assumed to travel whereas infec-
tious individuals (I) do not travel. We adopt a stochastic
framework in discrete time (with half-day time step), sim-
ilar to [5], to capture effects of chance, especially at the
source where the number of cases is still small. For each
city i in the absence of any intervention, epidemic dynam-
ics are described by the equations below (t tracks the time
of the epidemic's spread at the population level whereas τ
indicates the time since individual contamination):
Coupling of local epidemic dynamics is described by pop-
ulation flows from city i to city j (σij). Transition probabil-
ities between states are captured by distributions γ(τ)
(from E to I) and δ(τ) (from I to R). βi(t) = Στβsi(t)Ii(τ,t)/
ni is the probability that a susceptible individual becomes
infected at t+1 and is proportional to the basic transmis-
sion rate (β = R0, max/mean infectious duration) modulated
by the seasonality (s) and the proportion of infectious (I/
n). State variables in equation (1) are updated through
random variables following Binomial distributions (Bin)
which represent, in the order in which they appear in the
equations: the number of new infections, the number of
travelling latent subjects (in- and out-flows), the number
of new infectious individuals coming from other cities,
the number of new infectious individuals remaining in
the city of origin, and the number of newly recovered indi-
viduals.
Parameter values were chosen according to qualitative
knowledge or quantitative estimates. Consistent with
early estimates of the basic reproductive number from
data from the outbreak in Mexico [2,3], two plausible
pandemic profiles were tested: in the first, a maximum
(i.e. the value at the peak of transmissibility) basic repro-
ductive number (R0, max) value of 1.5 was assumed [3]
whereas in the second a higher R0, max, equal to 2.2, was
chosen [2]. For the first case, the mean generation interval
(GI) was assumed to equal 2 days (based on [3]) corre-
sponding to mean exposed and infectious durations equal
to 0.7 and 1.9 days respectively whereas in the second
case, the GI was set to 3.1 (a value suggested in [2]) and
the mean exposed and infectious durations were set equal
to 1.45 and 2.9 days respectively. In both cases appropri-
ate distributions of progression probabilities γ(τ) (with
τmax equal to 1 and 2 for the first and second pandemic
profiles respectively) and δ(τ) (with τmax equal to 4 and 7
respectively) were defined. As the average sojourn time in
the exposed state for the first pandemic profile is less than
a day, a time step of 0.5 days was adopted in order to cor-
rectly reproduce fast dynamic processes. The remaining
parameters were identical for both pandemic profiles as
detailed below. The observed seasonality in influenza
transmission was incorporated using a step function: from
October to March in the Northern hemisphere and the
rest of the year in the Southern hemisphere the transmis-
sibility (s) is maximum and equal to 1. The minimum
value was set at 0.4. In the tropics, transmissibility was
assumed constant over the year and equal to 0.7. Since no
information is available on the existence of cross-immu-
nity from past flu infections, the initial proportion of sus-
ceptible individuals was set to 100%. In agreement with
current knowledge and data [3], the case fatality rate was
assumed equal to 0.003. Deaths were counted but not
subtracted from the number of infectious individuals
since this does not appreciably impact on the dynamics of
infectious individuals. Under-reporting was not addressed
and no asymptomatic cases were considered. The pan-
demic originated in Mexico City where 20 cases were
assumed to be present on 1 April.
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Several scenarios for vaccination, introduced 6 months
after the start of the pandemic, were tested for each of the
two pandemic profiles. As little is known about the effi-
cacy of a future vaccine, coverage and efficacy were com-
bined into a unique intervention parameter through their
product. Each vaccination scenario was defined by the
duration of vaccination campaign and the number of cit-
ies where vaccination is implemented (all the cities or cit-
ies in developed countries only). Given that the objective
is to immunize a predetermined proportion (pv) of sus-
ceptibles (with respect to the number of vaccine doses
available at a given date) and that it seems reasonable to
assume that only a maximum proportion (α, put equal to
0.01) of current susceptibles can be vaccinated daily, we
fixed the duration (d) of the vaccination campaign at the
value satisfying the equation pv = 1-(1-α)d.
First, we assumed that the vaccine was available in devel-
oped countries only and that the vaccination campaign
lasted 15 days (corresponding to a proportion completely
immunized in developed countries of 14%). In the sec-
ond and the third scenarios, vaccination was imple-
mented in all cities of the network over 35 and 70 days
respectively (corresponding to global immunization rates
of 30% and 50% respectively). Results are expressed as
means calculated over 500 runs for each scenario.
Results and discussion
According to simulations from our model including a sea-
sonal forcing in flu transmission, for R0, max = 1.5 without
any preventive or control measures, the pandemic would
exhibit two waves (one in 2009 with a first Southern sub-
wave and a second Northern sub-wave and the other in
2010), mainly owing to two successive epidemic events in
Southern cities. In addition, the pattern would be differ-
ent with respect to the zone considered (Figure 1). In con-
trast to the South, one massive epidemic would occur in
the Northern hemisphere during the winter following the
first Southern peak. In tropical cities activity would be
moderate, spanning a much longer time period. The two-
waves spread has indeed been described among the "sig-
nature features of influenza pandemics" [1]. In the case of
a more transmissible viral strain (R0, max = 2.2), both the
first Southern wave and the following Northern wave
would be tremendous in size, affecting the vast majority
of susceptible individuals of these zones (86%, Table 1
and Figure 2). In this case, the same virus would not
spread the following year as a result of depletion of sus-
ceptibles.
Owing to the scale used in Figure 1, influenza transmis-
sion during the first three months after pandemic onset is
not visible on these graphs. However, simulated dynamics
show early influenza activity with a daily worldwide inci-
dence lower than 1/100000, which is consistent with the
present situation (52160 cases of influenza A(H1N1) in
99 countries on 22 June 2009).
In the case of a moderately transmissible virus with R0, max
= 1.5, 46% of the population would be infected world-
wide by the end of 2010, mostly in Northern and South-
ern zones (Table 1), if no preventive or control measure
were implemented. This proportion would increase to
77% in the case of a higher R0, max = 2.2. Although these
attack rates may be over-estimated because of the assump-
tion of an entirely susceptible and completely mixing
population, the predicted values are not unrealistic com-
pared with past pandemics. However, it is difficult to pro-
vide a more accurate prediction since no information is
available on the existence of cross-immunity from past flu
infections.
The impact of vaccination differs according to the pan-
demic profiles and intervention scenarios. For the first
pandemic profile (R0, max = 1.5 and GI = 2), making vac-
cine available in developed countries only and vaccinat-
ing 14% of the population does not change the global
pattern of pandemic spread but reduces the global attack
rate by 20% (Figure 3 and Table 1). The benefit, in terms
of number of cases, is noteworthy in the Northern zone
(where most developed countries are located) but is quite
low in the Southern and Tropical regions (Table 1). In the
third and fourth vaccination scenarios, where vaccination
is implemented in all countries (30% and 50% of suscep-
tibles are vaccinated respectively), the pandemic exhibits
only a first wave and mainly in Southern cities (Figures 4
and 5). Mean global attack rates are significantly lower
(9% and 4% respectively) and benefits are more homoge-
neously distributed among zones. However, the pan-
demic burden in the South is still important since the
arrival of an effective vaccine 6 months after the start of
the pandemic is unable to prevent the first wave in this
region. Significant decreases in the global pandemic bur-
den could be recorded for even smaller immunization
proportions: if 20% (or 25%) of susceptibles are vacci-
nated, the mean global attack rate decreases to 21% (or
16%) (results not shown in Table 1).
The impact of vaccination is globally diminished in the
case of a more transmissible influenza virus and a longer
mean infectious duration (R0, max = 2.2 and GI = 3.1)
(Table 1 and Figure 6). Even in the presence of a mass vac-
cination campaign (50% of population immunized),
43% of the population would still contract the infection.
This is again explained by the fact that the large majority
of cases (all the cases in the Southern cities) occur in the
first 6 months, before the onset of vaccination.
In addition to intrinsic differences in the dynamics of the
two pandemic scenarios (induced by different values ofBMC Infectious Diseases 2009, 9:129 http://www.biomedcentral.com/1471-2334/9/129
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Baseline scenario, no vaccination (R0, max = 1.5 and GI = 2) Figure 1
Baseline scenario, no vaccination (R0, max = 1.5 and GI = 2). Dynamics of the pandemic starting from Mexico City, in late 
March 2009, in the absence of preventive and control measures. The upper panel represents average daily incidences for 
Northern (green), Southern (blue), tropical (black) and all (red) cities. Plain lines correspond to means and dashed lines (for 
the global curve only) to .05 and .95 pointwise quantiles calculated on 500 simulation runs. The lower panel illustrates the 
spread of the virus through the 52 cities of the network; the predicted probability of influenza activity is represented for each 
city (from 0 (white) to 1 (black)).
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R0, max and of GI duration), the two-waves or one-wave
patterns are partly due to seasonal forcing. As specified in
the Methods, we considered that the transmissibility was
2.5 times greater during the influenza season in Northern
and Southern zones (6 months in each hemisphere) than
the rest of the year. In tropical regions the transmissibility
was set to a constant throughout the year equal to 70% of
the transmissibility during the influenza season in the
North and South. The choice of a step function to repre-
sent variation in transmissibility and of the ratios between
epidemic and non-epidemic seasons has a non-negligible
impact on the simulated dynamic pattern. Further investi-
gations are needed to evaluate their importance on the
dynamics of the new circulating H1N1 strain.
All simulations are performed in the stochastic framework
which allows capturing various effects of chance, espe-
cially at the source where the number of cases is still small.
Results on final pandemic burdens, although based on
stochastic runs, are quite stable and concentrated around
the mean as illustrated in Figure 6.
As little information exists on the efficacy of any future
vaccine, coverage and efficacy were summarized by a sin-
gle parameter representing the proportion of the popula-
tion effectively immunized. This approach is a rough
approximation to reality and can be interpreted in several
ways. For example, a 14% vaccine-induced immunity in
the population may be the result of vaccinating 20% of
population with a 70% effective vaccine or of vaccinating
70% of over 60 year-olds, assuming that the latter make
up 20% of the population of developed countries. It will
be possible to refine this approach as age-dependent ini-
tial natural immunity and transmissibility are further
characterized. Beyond the specific case of vaccination, this
kind of scenario could represent any preventive and con-
trol measure designed to protect susceptible individuals.
Finally, it is interesting to note that a scenario starting in
Mexico City was already identified in previous work [8]
exploring possible pandemic profiles. Here we refine our
model used in [8] by adopting a stochastic framework and
adapting this scenario to parameter estimates closer to
those currently reported. Although the prediction con-
cerning the Mexico City pandemic outlined in our previ-
ous study could have been altered by using a different
classification method, it nevertheless remains that this
scenario seemed to be a typical one. Our first prediction
in [8] did not indicate a rule for identifying a pandemic-
source location but it did provide some insight on how a
pandemic would spread if starting in such a place. Ulti-
mately, this finding was not surprising since Mexico City
is well connected to the rest of the world and belongs to
the tropical zone where viral strains circulate all year.
These are two important characteristics for "successful"
influenza spread.
Conclusion
Although much remains to be done to characterize the
new strain further, this study, based on models including
estimates close to recently published data, shows that a
multi-wave pandemic with a large attack rate is possible
and may be curtailed using different immunization strat-
egies.
Table 1: Forecasted total attack and mortality rates for two pandemic profiles (R0, max = 1.5 and GI = 2 versus R0, max = 2.2 and GI = 3.1)
Scenario Total attack rate (%) Total attack rate 
North (%)
Total attack rate 
South (%)
Total attack rate 
Tropics (%)
Mortality rate (%)
R0, max = 
1.5
GI = 2
R0, max = 
2.2
GI = 3.1
R0, max = 
1.5
GI = 2
R0, max = 
2.2
GI = 3.1
R0, max = 
1.5
GI = 2
R0, max = 
2.2
GI = 3.1
R0, max = 
1.5
GI = 2
R0, max = 
2.2
GI = 3.1
R0, max = 
1.5
GI = 2
R0, max = 
2.2
GI = 3.1
No 
vaccination
46 77 62 86 58 86 19 62 0.14 0.23
Vaccinatio
n in 
developed 
countries 
(14%)
37 71 47 74 55 86 17 62 0.11 0.21
Vaccinatio
n in all 
countries 
(30%)
9 5 11 14 53 28 62 5 20 . 0 3 0 . 1 5
Vaccinatio
n in all 
countries 
(50%)
4 43 1 31 32 86 2 52 0.01 0.13
Means of attack and mortality rates in the absence of any intervention and under different vaccination scenarios are calculated on 500 simulation 
runs for each scenario.BMC Infectious Diseases 2009, 9:129 http://www.biomedcentral.com/1471-2334/9/129
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Comparison between baseline scenarios (R0, max = 1.5 and GI = 2 versus R0, max = 2.2 and GI = 3.1), no vaccination Figure 2
Comparison between baseline scenarios (R0, max = 1.5 and GI = 2 versus R0, max = 2.2 and GI = 3.1), no vaccina-
tion. Dynamics of the pandemic starting from Mexico City, in late March 2009, in the absence of preventive and control meas-
ures for two pandemic profiles (R0, max = 1.5 and GI = 2 (red); versus R0, max = 2.2 and GI = 3.1 (blue)). Graphs represent 
average daily incidences calculated on 500 simulation runs: for all cities of the network (upper panel) and specifically for cities 
in each zone (North, South and Tropics; lower panels).
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Vaccination in developed countries only, 14% of population are immunized (R0, max = 1.5 and GI = 2) Figure 3
Vaccination in developed countries only, 14% of population are immunized (R0, max = 1.5 and GI = 2). Dynamics of 
the pandemic starting from Mexico City, in late March 2009, with vaccine available only in developed countries 6 months after 
pandemic onset. Fourteen percent of the population in developed countries are vaccinated at a daily rate of 1%. The upper 
panel represents average daily incidences for Northern (green), Southern (blue), tropical (black) and all (red) cities. Plain lines 
correspond to means and dashed lines (for the global curve only) to .05 and .95 pointwise quantiles calculated on 500 simula-
tion runs. The lower panel illustrates the spread of the virus through the 52 cities of the network; the predicted probability of 
influenza activity is represented for each city (from 0 (white) to 1 (black)).
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Vaccination in all countries, 30% of population are immunized (R0, max = 1.5 and GI = 2) Figure 4
Vaccination in all countries, 30% of population are immunized (R0, max = 1.5 and GI = 2). Dynamics of the pandemic 
starting from Mexico City, in late March 2009, with vaccine available in all countries 6 months after the pandemic onset. Thirty 
percent of worldwide population are vaccinated at a daily rate of 1%. The upper panel represents average daily incidences for 
Northern (green), Southern (blue), tropical (black) and all (red) cities. Plain lines correspond to means and dashed lines (for 
the global curve only) to .05 and .95 pointwise quantiles calculated on 500 simulation runs. The lower panel illustrates the 
spread of the virus through the 52 cities of the network; the predicted probability of influenza activity is represented for each 
city (from 0 (white) to 1 (black)).
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Vaccination in all countries, 50% of population are immunized (R0, max = 1.5 and GI = 2) Figure 5
Vaccination in all countries, 50% of population are immunized (R0, max = 1.5 and GI = 2). Dynamics of the pandemic 
starting from Mexico City, in late March 2009, with vaccine available in all countries 6 months after the pandemic onset. Fifty 
percent of worldwide population are vaccinated at a daily rate of 1%. The upper panel represents average daily incidences for 
Northern (green), Southern (blue), tropical (black) and all (red) cities. Plain lines correspond to means and dashed lines (for 
the global curve only) to .05 and .95 pointwise quantiles calculated on 500 simulation runs. The lower panel illustrates the 
spread of the virus through the 52 cities of the network; the predicted probability of influenza activity is represented for each 
city (from 0 (white) to 1 (black)).
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